Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 754,739 | 720,444 | 65,442 | N/A | N/A |
| Marketable Securities | 2,272 | 2,249 | 2,201 | N/A | N/A |
| Receivables | 26,697 | 50,889 | 88,244 | N/A | N/A |
| Inventories | 49,303 | 40,613 | 39,572 | N/A | N/A |
| TOTAL | $854,245 | $833,319 | $215,729 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 63,997 | 61,315 | 67,817 | N/A | N/A |
| Intangibles | 19,344 | 19,344 | 19,344 | 0 | 0 |
| Other Non-Current Assets | 46,985 | 41,080 | 40,844 | 0 | 0 |
| TOTAL | $130,326 | $121,739 | $128,005 | $N/A | $N/A |
| Total Assets | $984,571 | $955,058 | $343,734 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 164 | 95 | 60,090 | N/A | N/A |
| Accounts payable and accrued liabilities | 28,999 | 28,728 | 27,791 | 0 | 0 |
| Accrued Expenses | 56,867 | 61,357 | 77,542 | N/A | N/A |
| TOTAL | $86,030 | $90,180 | $165,423 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 376,296 | 373,611 | 319,438 | N/A | N/A |
| Other Non-Current Liabilities | 43,881 | 38,363 | 2,357,711 | 0 | 0 |
| TOTAL | $420,177 | $411,974 | $2,677,149 | $N/A | $N/A |
| Total Liabilities | $506,207 | $502,154 | $2,842,572 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 282,147 | 281,224 | N/A | N/A | N/A |
| Common Shares | 283 | 282 | 38 | N/A | N/A |
| Retained earnings | -2,630,693 | -2,655,018 | -2,472,300 | N/A | N/A |
| Other shareholders' equity | 831 | 752 | -26,576 | 0 | 0 |
| TOTAL | $478,364 | $452,904 | $-2,498,838 | $N/A | $N/A |
| Total Liabilities And Equity | $984,571 | $955,058 | $343,734 | $0 | $0 |